Literature DB >> 24630294

Risk of gestational diabetes mellitus in patients undergoing assisted reproductive techniques.

M Ashrafi1, R Gosili2, R Hosseini2, A Arabipoor2, J Ahmadi2, M Chehrazi3.   

Abstract

OBJECTIVE: To compare the incidence of gestational diabetes mellitus (GDM) between pregnancies conceived spontaneously and pregnancies conceived following assisted reproductive technology (ART). STUDY
DESIGN: This cross-sectional study evaluated the medical records of 215 women who conceived spontaneously and 145 women who conceived following ART from September 2011 to October 2012. Exclusion criteria were: polycystic ovary syndrome, maternal age ≥40 years, family history of diabetes in first-degree relatives, pre-pregnancy diabetes, glucose intolerance treated with hypoglycaemic agent (e.g. metformin), history of GDM, history of stillbirth, recurrent miscarriage, history of baby with birth weight ≥4kg (macrosomia), parity >3, Cushing syndrome, congenital adrenal hyperplasia and hypothyroidism. For better comparison of the incidence of GDM, the ART group was further subdivided into: (i) an in-vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) group (n=95); and (ii) an intrauterine insemination (IUI) group (n=50). The diagnosis of GDM was based on the criteria of the American Diabetes Association.
RESULTS: The incidence of GDM was significantly higher in the IVF/ICSI and IUI groups (43% and 26%, respectively) compared with the spontaneous pregnancy group (10%). Age, pre-pregnancy body mass index (BMI) and weight gain in pregnancy were similar among women with GDM in all three groups. In addition, the incidence of pregnancy-induced hypertension was significantly higher in the IVF/ICSI group (21%) compared with the spontaneous pregnancy group (7%). Logistic regression analysis demonstrated four strong risk factors for GDM: age, BMI, mode of ART and progesterone use during pregnancy.
CONCLUSION: This study indicated that the risk of GDM is two-fold higher in women with singleton pregnancies conceived following ART compared with women who conceived spontaneously. In addition, progesterone use during pregnancy was found to be an important risk factor for GDM. This subject requires further study.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Assisted reproductive techniques; Gestational diabetes mellitus; Risk factors

Mesh:

Year:  2014        PMID: 24630294     DOI: 10.1016/j.ejogrb.2014.02.009

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  18 in total

1.  The first 50 live births after autologous oocyte vitrification in France.

Authors:  Any Beltran Anzola; Vanessa Pauly; Cendrine Geoffroy-Siraudin; Marie-José Gervoise-Boyer; Debbie Montjean; Pierre Boyer
Journal:  J Assist Reprod Genet       Date:  2015-10-30       Impact factor: 3.412

Review 2.  In Vitro fertilization and adverse obstetric and perinatal outcomes.

Authors:  Chantae S Sullivan-Pyke; Suneeta Senapati; Monica A Mainigi; Kurt T Barnhart
Journal:  Semin Perinatol       Date:  2017-08-14       Impact factor: 3.300

3.  Analysis of the main risk factors for gestational diabetes diagnosed with International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria in multiple pregnancies.

Authors:  M Cozzolino; C Serena; L Maggio; M P Rambaldi; S Simeone; G Mello; L Pasquini; M Di Tommaso; F Mecacci
Journal:  J Endocrinol Invest       Date:  2017-03-21       Impact factor: 4.256

4.  Obstetric and perinatal complications associated with assisted reproductive treatment in Spain.

Authors:  Ana Ballesta-Castillejos; Juan Gomez-Salgado; Julian Rodriguez-Almagro; Inmaculada Ortiz-Esquinas; Antonio Hernández-Martínez
Journal:  J Assist Reprod Genet       Date:  2019-11-18       Impact factor: 3.412

5.  Pregnancy outcomes and maternal and perinatal complications of pregnancies following in vitro fertilization/intracytoplasmic sperm injection using own oocytes, donor oocytes, and vitrified embryos: A prospective follow-up study.

Authors:  Manish Banker; Vidhisha Mehta; Dipesh Sorathiya; Mira Dave; Sandeep Shah
Journal:  J Hum Reprod Sci       Date:  2016 Oct-Dec

Review 6.  Advanced maternal age and adverse pregnancy outcomes: A systematic review and meta-analysis.

Authors:  Samantha C Lean; Hayley Derricott; Rebecca L Jones; Alexander E P Heazell
Journal:  PLoS One       Date:  2017-10-17       Impact factor: 3.240

7.  Risk of gestational diabetes mellitus in women achieving singleton pregnancy spontaneously or after ART: a systematic review and meta-analysis.

Authors:  Julia K Bosdou; Panagiotis Anagnostis; Dimitrios G Goulis; Georgios T Lainas; Basil C Tarlatzis; Grigoris F Grimbizis; Efstratios M Kolibianakis
Journal:  Hum Reprod Update       Date:  2020-06-18       Impact factor: 15.610

Review 8.  Prevalence of type 2 diabetes, prediabetes, and gestational diabetes mellitus in women of childbearing age in Middle East and North Africa, 2000-2017: protocol for two systematic reviews and meta-analyses.

Authors:  Rami H Al-Rifai; Faisal Aziz
Journal:  Syst Rev       Date:  2018-07-18

9.  Risk for Gestational Diabetes Mellitus and Adverse Birth Outcomes in Chinese Women with Polycystic Ovary Syndrome.

Authors:  Qing Xiao; Yong-Yi Cui; Jine Lu; Guo-Zheng Zhang; Fang-Ling Zeng
Journal:  Int J Endocrinol       Date:  2016-03-14       Impact factor: 3.257

10.  Maternal hyperglycemia in singleton pregnancies conceived by IVF may be modified by first-trimester BMI.

Authors:  S Cai; P Natarajan; J K Y Chan; P C Wong; K H Tan; K M Godfrey; P D Gluckman; L P C Shek; F Yap; M S Kramer; S Y Chan; Y S Chong
Journal:  Hum Reprod       Date:  2017-09-01       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.